Jump to content

RB-3007

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by BOBBOBLEYBOBSON (talk | contribs) at 03:16, 6 April 2018 (added categories). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

RB-3007 is an orally active analogue of RB-101. It acts as an enkephalinase inhibitor, which is used in scientific research [1][2][3]

References

  1. ^ Thanawala, V.; Kadam, V.; Ghosh, R. (1 October 2008). "Enkephalinase Inhibitors: Potential Agents for the Management of Pain". Current Drug Targets. 9 (10): 887–894. doi:10.2174/138945008785909356.
  2. ^ Noble, Florence; Roques, Bernard P (17 January 2007). "Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs". Expert Opinion on Therapeutic Targets. 11 (2): 145–159. doi:10.1517/14728222.11.2.145.
  3. ^ Thanawala, V.; Kadam, V.; Ghosh, R. (1 October 2008). "Enkephalinase Inhibitors: Potential Agents for the Management of Pain". Current Drug Targets. 9 (10): 887–894. doi:10.2174/138945008785909356.
Retrieved from "https://en.wikipedia.org/w/index.php?title=RB-3007&oldid=834515186"